abstract |
The present application discloses a compound of formula (I): wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and therapeutics with BMP1, TLL1 and/or TLL2 Use of a disease associated with TLL1 and/or TLL2 activity. |